Have you heard of Farxiga (dapagliflozin), Jardiance (empagliflozin), Ozempic, Wegovy, Mounjaro, or finerenone, but aren’t quite sure what they do or whether they’re right for people living with kidney disease?
In this episode of Diary of a Kidney Warrior Podcast, host Dee Moore is joined by Professor Alex, Consultant Nephrologist and researcher, for an essential conversation about some of the biggest breakthroughs in kidney medicine in recent years.
Originally developed for diabetes, SGLT2 inhibitors have transformed kidney care and are now helping to protect kidney function, reduce protein in the urine and improve outcomes for many people living with chronic kidney disease (CKD). We also explore the growing role of GLP-1 receptor agonists and finerenone, and explain what patients need to know about these treatments.
Whether you’re living with chronic kidney disease, caring for someone who is, or you’re a healthcare professional wanting a patient-friendly explanation, this episode is packed with practical, evidence-based information.
In this episode, you’ll learn:
✅ What SGLT2 inhibitors are and how they protect the kidneys
✅ Why medications developed for diabetes are now transforming kidney care
✅ How GLP-1 receptor agonists (including Ozempic, Wegovy and Mounjaro) may benefit kidney health
✅ What finerenone is and who may benefit from it
✅ Why your eGFR may temporarily fall after starting treatment—and why this isn’t always a cause for concern
✅ The benefits and possible side effects of these medications
✅ Which kidney patients may be suitable for these treatments
✅ The latest developments in kidney research and future treatments
This episode shares expert insight designed to educate, empower and inspire people living with kidney disease and those who support them.
🎥 Prefer to watch? The full video version of this episode is also available on the Diary of a Kidney Warrior Podcast YouTube channel:
https://youtu.be/wIigNxUEXyI
💚 If you found this episode helpful, please:
⭐ Follow or subscribe to Diary of a Kidney Warrior Podcast
⭐ Leave a rating and review on your favourite podcast platform
⭐ Share this episode with family, friends, your renal team and anyone living with kidney disease—it could make a real difference.
Follow Diary of a Kidney Warrior:
📸Instagram: www.instagram.com/diaryofakidneywarrior
📘Facebook: www.facebook.com/diaryofakidneywarrior
🐦Twitter (X): www.twitter.com/diaryofakidneyw
🎵Tik Tok: @diaryofakidneywarrior
📺Youtube: https://www.youtube.com/channel/UChGUfib7lu9eKENlLJ6lafw
🔵 BlueSky: @diaryofakidneyw.bsky.social
💌 Join the Diary of a Kidney Warrior Family Mailing List
Get updates on new episodes, vlogs, newsletters, and more!
👉🏽👉 Sign up here: https://diaryofakidneywarrior.getform.com/rjv47
📲 Follow Diary of a Kidney Warrior on WhatsApp
Stay updated with new episodes and exclusive content!
👉🏽👉 Join here: https://whatsapp.com/channel/0029VaO3ms71iUxipp1eeh2r
Follow Professor Alex:
🔗LinkedIn: https://uk.linkedin.com/in/alexander-woywodt-380a9834
Follow Kidney Care UK
💻 Website: www.kidneycareuk.org
📧 info@kidneycareuk.org
📞Tel: 01420 541 424
📘Facebook: www.facebook.com/kidneycareuk.org
📷Instagram: @kidneycareuk
🔵Blue Sky: https://bsky.app/profile/kidneycareuk.bsky.social
📺YouTube: https://www.youtube.com/channel/UCeqQTdAsEzXphqjHVtcTD-A
📩 To sign up to receive the Kidney Matters Quarterly Magazine Email: info@kidneycareuk.org (UK only)
Disclaimer:
The information shared in this episode is for educational and informational purposes only and does not constitute medical advice. Always consult your doctor, consultant, or qualified healthcare professional regarding your individual health needs and before making any medical decisions. The views expressed by guests are their own and do not necessarily reflect those of the host, the Diary of a Kidney Warrior Podcast, or Kidney Care UK and are not intended to malign any religion, ethnic group, club, organisation, company, individual or anyone or anything.
#DiaryOfAKidneyWarriorPodcast #KidneyDisease #ChronicKidneyDisease #CKD #KidneyHealth #KidneyFailure #Nephrology #KidneyPatient #KidneyCare #SGLT2 #SGLT2Inhibitors #GLP1 #Finerenone #Farxiga #Jardiance #Ozempic #Wegovy #Mounjaro #Proteinuria #eGFR #Diabetes #KidneyResearch #Renal #Healthcare #PatientEducation #renal #healthpodcastseries #healthpodcast